Pharmacological Profile of (2R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor Antagonist
Megens, A A H P, Ashton, D, Vermeire, J C A, Vermote, P C M, Hens, K A, Hillen, L C, Fransen, J F, Mahieu, M, Heylen, L, Leysen, J E, Jurzak, M R, Janssens, F
Published in The Journal of pharmacology and experimental therapeutics (01.08.2002)
Published in The Journal of pharmacology and experimental therapeutics (01.08.2002)
Get full text
Journal Article
Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha(2)-adrenoceptor blocking activity
Andres, JI, Alcazar, J, Alonso, JM, Alvarez, RM, Bakker, MH, Biesmans, Cid, JM, De Lucas, AI, Fernandez, J, Font, LM, Hens, KA, Iturrino, L, Lenaerts, Martinez, S, Megens, AA, Pastor, J, Vermote, PCM, Steckler, T
Published in Journal of medicinal chemistry (24.03.2005)
Published in Journal of medicinal chemistry (24.03.2005)
Get full text
Journal Article
Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with alpha sub(2)-Adrenoceptor Blocking Activity
Andres, JI, Alcazar, J, Alonso, J M, Alvarez, R M, Bakker, M H, Biesmans, I, Cid, J M, De Lucas, AI, Fernandez, J, Font, L M, Hens, KA, Iturrino, L, Lenaerts, I, Martinez, S
Published in Journal of medicinal chemistry (24.03.2005)
Published in Journal of medicinal chemistry (24.03.2005)
Get full text
Journal Article